| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2023-05-30 20:56:01 UTC |
|---|
| HMDB ID | HMDB0000699 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 1-Methylnicotinamide |
|---|
| Description | 1-Methylnicotinamide, also known as trigonellinamide or trigonellamide chloride, belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. 1-Methylnicotinamide exists in all living species, ranging from bacteria to plants to humans. 1-Methylnicotinamide has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make 1-methylnicotinamide a potential biomarker for the consumption of these foods. 1-Methylnicotinamide is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on 1-Methylnicotinamide. |
|---|
| Structure | InChI=1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Methyl nicotinamide | ChEBI | | 1-Methylnicotinamide cation | ChEBI | | 3-(Aminocarbonyl)-1-methylpyridinium | ChEBI | | 3-Carbamoyl-1-methylpyridin-1-ium | ChEBI | | N(1)-Methylnicotinamide | ChEBI | | N-1-Methylnicotinamide | ChEBI | | Trigonellinamide | ChEBI | | 1-Methyl-3-carbamoylpyridinium | HMDB | | 1-Methyl-3-carbamoylpyridinium cation | HMDB | | 3-Amido-N-methylpyridinium: 1-methyl-3-pyridinecarboxamide | HMDB | | 3-Carbamoyl-1-methyl-pyridinium | HMDB | | I-methyl nicotinamide | HMDB | | N'-methylnicotinamide | HMDB | | N'Methylnicotinamide | HMDB | | N-Methyl-3-carbamidopyridinium | HMDB | | N-Methyl-3-carbamoylpyridinium ion | HMDB | | N1-Methylnicotinamide | HMDB | | N(1)-Methylnicotinamide chloride | HMDB | | N(1)-Methylnicotinamide cyanide | HMDB | | N(1)-Methylnicotinamide fluoride | HMDB | | N(1)-Methylnicotinamide iodide, 3-(aminocarbonyl-13C)-labeled | HMDB | | N(1)-Methylnicotinamide methylsulfate | HMDB | | N(1)-Methylnicotinamide perchlorate | HMDB | | N(1)-Methylnicotinamide bromide | HMDB | | N(1)-Methylnicotinamide iodide | HMDB | | N(1)-Methylnicotinamide tetrafluoroborate (1-) | HMDB | | Trigonellamide chloride | HMDB |
|
|---|
| Chemical Formula | C7H9N2O |
|---|
| Average Molecular Weight | 137.1592 |
|---|
| Monoisotopic Molecular Weight | 137.07148792 |
|---|
| IUPAC Name | 3-carbamoyl-1-methylpyridin-1-ium |
|---|
| Traditional Name | 1-methylnicotinamide |
|---|
| CAS Registry Number | 3106-60-3 |
|---|
| SMILES | C[N+]1=CC=CC(=C1)C(N)=O |
|---|
| InChI Identifier | InChI=1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1 |
|---|
| InChI Key | LDHMAVIPBRSVRG-UHFFFAOYSA-O |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Pyridines and derivatives |
|---|
| Sub Class | Pyridinecarboxylic acids and derivatives |
|---|
| Direct Parent | Nicotinamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Nicotinamide
- N-methylpyridinium
- Pyridinium
- Heteroaromatic compound
- Vinylogous amide
- Carboxamide group
- Primary carboxylic acid amide
- Carboxylic acid derivative
- Azacycle
- Organic nitrogen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic cation
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 855 mg/mL | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.56 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.2455 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.27 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 93.3 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1003.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 305.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 91.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 182.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 51.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 240.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 280.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 241.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 669.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 39.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 817.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 201.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 211.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 506.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 295.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 140.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 1-Methylnicotinamide,1TMS,isomer #1 | C[N+]1=CC=CC(C(=O)N[Si](C)(C)C)=C1 | 1541.7 | Semi standard non polar | 33892256 | | 1-Methylnicotinamide,1TMS,isomer #1 | C[N+]1=CC=CC(C(=O)N[Si](C)(C)C)=C1 | 1547.6 | Standard non polar | 33892256 | | 1-Methylnicotinamide,1TMS,isomer #1 | C[N+]1=CC=CC(C(=O)N[Si](C)(C)C)=C1 | 1759.0 | Standard polar | 33892256 | | 1-Methylnicotinamide,2TMS,isomer #1 | C[N+]1=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C1 | 1572.1 | Semi standard non polar | 33892256 | | 1-Methylnicotinamide,2TMS,isomer #1 | C[N+]1=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C1 | 1601.0 | Standard non polar | 33892256 | | 1-Methylnicotinamide,2TMS,isomer #1 | C[N+]1=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C1 | 1745.5 | Standard polar | 33892256 | | 1-Methylnicotinamide,1TBDMS,isomer #1 | C[N+]1=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C1 | 1760.1 | Semi standard non polar | 33892256 | | 1-Methylnicotinamide,1TBDMS,isomer #1 | C[N+]1=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C1 | 1716.8 | Standard non polar | 33892256 | | 1-Methylnicotinamide,1TBDMS,isomer #1 | C[N+]1=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C1 | 1918.1 | Standard polar | 33892256 | | 1-Methylnicotinamide,2TBDMS,isomer #1 | C[N+]1=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 2019.6 | Semi standard non polar | 33892256 | | 1-Methylnicotinamide,2TBDMS,isomer #1 | C[N+]1=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 2000.8 | Standard non polar | 33892256 | | 1-Methylnicotinamide,2TBDMS,isomer #1 | C[N+]1=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 1983.3 | Standard polar | 33892256 |
|
|---|
| Spectra |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 1-Methylnicotinamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-5900000000-5a5fd45836c387d92371 | 2016-09-22 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 1-Methylnicotinamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-000i-0900000000-c99e0e70357eb6fa74bb | 2012-07-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-0006-9000000000-93675f2b9efbaba4d471 | 2012-07-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0fvl-9000000000-b1e908db583e418c2545 | 2012-07-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-000i-0900000000-9c3104d60f21f6375b0c | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-000i-1900000000-e500f262d42edb9b3ad7 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-0006-9200000000-496b2cf62a07bea4f746 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-002f-9000000000-a17b3a63979577f6fa9e | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-00ou-9000000000-46a856cd097a7a14dc90 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive-QTOF | splash10-000l-6900000000-360fb882a925f7e9edc9 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 30V, Positive-QTOF | splash10-0006-9000000000-babd4e89db309a5c74cf | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ , positive-QTOF | splash10-000i-0900000000-9c3104d60f21f6375b0c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ , positive-QTOF | splash10-000i-1900000000-e500f262d42edb9b3ad7 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ , positive-QTOF | splash10-0006-9200000000-052c844f974abba065eb | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ , positive-QTOF | splash10-002f-9000000000-a17b3a63979577f6fa9e | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ , positive-QTOF | splash10-00ou-9000000000-2fe6c195129f32a62a3c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QTOF , positive-QTOF | splash10-000l-6900000000-360fb882a925f7e9edc9 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QTOF , positive-QTOF | splash10-0006-9000000000-babd4e89db309a5c74cf | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide , positive-QTOF | splash10-000i-0900000000-08a578fa81c8d41a4fe6 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 10V, Positive-QTOF | splash10-000i-0900000000-d889aade6d1014ffb393 | 2016-09-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 20V, Positive-QTOF | splash10-004r-1900000000-8052aba6067c868e594f | 2016-09-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 40V, Positive-QTOF | splash10-00di-9500000000-579bc8310420ec3d8786 | 2016-09-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 10V, Negative-QTOF | splash10-000i-0900000000-141e3a418b748abf9e1d | 2016-09-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 20V, Negative-QTOF | splash10-000i-1900000000-33499eeb5abff5a8b53b | 2016-09-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 40V, Negative-QTOF | splash10-0006-9100000000-e45f804a013c97310f00 | 2016-09-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 10V, Positive-QTOF | splash10-000i-2900000000-5527bd16347dfbb8af1b | 2021-09-21 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Experimental 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
|---|
| Biological Properties |
|---|
| Cellular Locations | |
|---|
| Biospecimen Locations | |
|---|
| Tissue Locations | |
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 0.430 (0.007-0.850) uM | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 6.105 (0.240-12.0) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 0.82 (0.26-2.3) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | | Urine | Detected and Quantified | 1.9 (0.67-5.1) umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 3.5 (1.3-6.0) umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | | Urine | Detected and Quantified | 4.8 (1.86-13.94) umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | | Urine | Detected and Quantified | 2.5 (2.1-2.8) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 5.8 (1.2-15.0) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 7.749 +/- 7.16 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 61.37 (40.64-92.98) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details |
|
|---|
| Abnormal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 0.099-0.851 uM | Adult (>18 years old) | Both | Cirrhosis | | details | | Urine | Detected and Quantified | 3.0 (0.0-14.0) umol/mmol creatinine | Adult (>18 years old) | Both | Lung cancer | | details | | Urine | Detected and Quantified | 37.00 (11.5-62.7) umol/mmol creatinine | Adult (>18 years old) | Both | Pellagra | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Autosomal dominant polycystic kidney disease (ADPKD) | | details | | Urine | Detected and Quantified | 7.426 +/- 3.509 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details |
|
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | | Cirrhosis |
|---|
- Somogyi A, Siebert D, Bochner F: Determination of endogenous concentrations of N1-methylnicotinamide in human plasma and urine by high-performance liquid chromatography. Anal Biochem. 1990 May 15;187(1):160-5. [PubMed:2142586 ]
| | Lung Cancer |
|---|
- Stretch C, Eastman T, Mandal R, Eisner R, Wishart DS, Mourtzakis M, Prado CM, Damaraju S, Ball RO, Greiner R, Baracos VE: Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach. J Nutr. 2012 Jan;142(1):14-21. doi: 10.3945/jn.111.147751. Epub 2011 Dec 7. [PubMed:22157537 ]
| | Pellagra |
|---|
- Creeke PI, Dibari F, Cheung E, van den Briel T, Kyroussis E, Seal AJ: Whole blood NAD and NADP concentrations are not depressed in subjects with clinical pellagra. J Nutr. 2007 Sep;137(9):2013-7. [PubMed:17709435 ]
| | Autosomal dominant polycystic kidney disease |
|---|
- Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Boger CA, Banas B, Eckardt KU, Oefner PJ: Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int. 2011 Jun;79(11):1244-53. doi: 10.1038/ki.2011.30. Epub 2011 Mar 9. [PubMed:21389975 ]
| | Eosinophilic esophagitis |
|---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
|---|
| Associated OMIM IDs | - 211980 (Lung Cancer)
- 601313 (Autosomal dominant polycystic kidney disease)
- 610247 (Eosinophilic esophagitis)
|
|---|
| External Links |
|---|
| DrugBank ID | DB11710 |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB022188 |
|---|
| KNApSAcK ID | C00052106 |
|---|
| Chemspider ID | 444 |
|---|
| KEGG Compound ID | C02918 |
|---|
| BioCyc ID | CPD-396 |
|---|
| BiGG ID | 2226225 |
|---|
| Wikipedia Link | 1-Methylnicotinamide |
|---|
| METLIN ID | 5667 |
|---|
| PubChem Compound | 457 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 16797 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | 1MNCAM |
|---|
| MarkerDB ID | MDB00000225 |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Nelis, Hans J. C. F.; Airy, Subhash C.; Sinsheimer, J. E. Comparison of the alkylation of nicotinamide and 4-(p-nitrobenzyl)pyridine for the determination of aliphatic epoxides. Analytical Chemistry (1982), 54(2), 213-16. |
|---|
| Material Safety Data Sheet (MSDS) | Not Available |
|---|
| General References | - Ohdoi C, Nyhan WL, Kuhara T: Chemical diagnosis of Lesch-Nyhan syndrome using gas chromatography-mass spectrometry detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 15;792(1):123-30. [PubMed:12829005 ]
- Pelletier O, Brassard R: Automated and manual determination of N1-methylnicotinamide in urine. Am J Clin Nutr. 1977 Dec;30(12):2108-16. [PubMed:145178 ]
- Carter EG: Quantitation of urinary niacin metabolites by reversed-phase liquid chromatography. Am J Clin Nutr. 1982 Nov;36(5):926-30. [PubMed:6215856 ]
- Slominska EM, Smolenski RT, Szolkiewicz M, Leaver N, Rutkowski B, Simmonds HA, Swierczynski J: Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure. Mol Cell Biochem. 2002 Feb;231(1-2):83-8. [PubMed:11952169 ]
- Patterson JI, Brown RR, Linkswiler H, Harper AE: Excretion of tryptophan-niacin metabolites by young men: effects of tryptophan, leucine, and vitamin B6 intakes. Am J Clin Nutr. 1980 Oct;33(10):2157-67. [PubMed:6448542 ]
- Musfeld C, Biollaz J, Belaz N, Kesselring UW, Decosterd LA: Validation of an HPLC method for the determination of urinary and plasma levels of N1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow. J Pharm Biomed Anal. 2001 Jan;24(3):391-404. [PubMed:11199218 ]
- Wozniacka A, Wieczorkowska M, Gebicki J, Sysa-Jedrzejowska A: Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. Clin Exp Dermatol. 2005 Nov;30(6):632-5. [PubMed:16197374 ]
- Chlopicki S, Swies J, Mogielnicki A, Buczko W, Bartus M, Lomnicka M, Adamus J, Gebicki J: 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. Br J Pharmacol. 2007 Sep;152(2):230-9. Epub 2007 Jul 16. [PubMed:17641676 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
|---|